UnitedHealth Group Incorporated $UNH Shares Sold by Quent Capital LLC

Quent Capital LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,645 shares of the healthcare conglomerate’s stock after selling 436 shares during the period. Quent Capital LLC’s holdings in UnitedHealth Group were worth $1,137,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP increased its holdings in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Bank of New York Mellon Corp increased its holdings in UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after purchasing an additional 196,696 shares during the period. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after acquiring an additional 847,054 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Barclays upped their target price on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Morgan Stanley upped their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. KeyCorp decreased their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Finally, Piper Sandler decreased their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Price Performance

UNH stock opened at $360.17 on Friday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The stock’s fifty day simple moving average is $307.84 and its 200-day simple moving average is $355.58. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business earned $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.